|
Clinical trials of sulfinpyrazone
Clinical trials of sulfinpyrazone and meta-analysis are available for the following clinical conditions:
acute coronary syndrome
acute coronary syndrome, antithrombotics, all type of patient
aspirin + sulfinpyrazone vs placebo :
Canadian (Aspirin + sulfinpyrazone), 1985
-
Canadian (sulfinpyrazone alone), 1985
-
acute coronary syndrome, antiplatelets drug, ACS (excluding AMI)
aspirin + sulfinpyrazone vs placebo :
Canadian (Aspirin + sulfinpyrazone), 1985
-
Canadian (sulfinpyrazone alone), 1985
-
acute coronary syndrome, antiplatelets drug, all type of patients
aspirin + sulfinpyrazone vs placebo :
Canadian (Aspirin + sulfinpyrazone), 1985
-
Canadian (sulfinpyrazone alone), 1985
-
acute myocardial infarction
acute myocardial infarction, antiplatelets drug, all type of patients
sulfinpyrazone vs control :
Dutch sulphinpyrazone, 1986
-
sulfinpyrazone vs placebo :
Wilcox, 1980
-
Louvain sulphinpyrazone, 1983
-
CABG surgery
CABG surgery, antiplatelets drug, all type of patients
sulfinpyrazone vs placebo :
Baur, 1982
-
Entry terms: Sulphinpyrazone, Sulfinpyrazone, Sulphinpyrazone, Sulfoxyphenylpyrazolidin, Nu-Sulfinpyrazone, Nu Sulfinpyrazone, Nu-Pharm Brand of Sulfinpyrazone, Nu Pharm Brand of Sulfinpyrazone, Anturane, Novartis Brand of Sulfinpyrazone, Anturan, Apo-Sulfinpyrazone, Apo Sulfinpyrazone, Apotex Brand of Sulfinpyrazone, G 33378, G-33378, 1-(4-hydroxyphenyl)-2-phenyl-4-(2-(phenylthio)ethyl)-3,5-pyrazolidinedione, G 25671, G-25671, 1,2-diphenyl-4-(2-(phenylthio)ethyl)-3,5-pyrazolidinedione, G 31442, G-31442, 1,2-diphenyl-4-(2-(phenylsulfonyl)ethyl)-3,5-pyrazolidinedione, 4-hydroxysulfinpyrazone, para-hydroxysulfinpyrazone
See also relatic topics:
Search sulfinpyrazone clinical trials in
Pubmed
Search sulfinpyrazone clinical trials in
ClinicalTrials.gov
Search sulfinpyrazone clinical trials in
Wikipedia
Search sulfinpyrazone in
drugs.com
browse_trt3
|
|